OOIR: Observatory of International Research

Papers

(The H4-Index of ACS Infectious Diseases is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential	237
Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease	214
Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients	182
Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin	120
Anti-SARS-CoV-2 Potential of Artemisinins In Vitro	113
Current and Perspective Diagnostic Techniques for COVID-19	111
Recent Innovations in Bacterial Infection Detection and Treatment	104
Multitarget Approaches against Multiresistant Superbugs	102
Are Quaternary Ammonium Compounds, the Workhorse Disinfectants, Effective against Severe Acute Respiratory Syndrome-Coronavirus-2?	91
Comparative Analysis of Primer–Probe Sets for RT-qPCR of COVID-19 Causative Virus (SARS-CoV-2)	89
Liposomes for Antibiotic Encapsulation and Delivery	83
Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies	78
Zoliflodacin: An Oral Spiropyrimidinetrione Antibiotic for the Treatment of Neisseria gonorrheae, Including Multi-Drug-Resistant Isolates	71
Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein–Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2	71
Synthetic Antimicrobial Polymers in Combination Therapy: Tackling Antibiotic Resistance	71
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses	67
Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19	67
Electrochemical Diagnostics for Bacterial Infectious Diseases	65
Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone	64
The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules	57
Effects of Antibiotic Treatment on Gut Microbiota and How to Overcome Its Negative Impacts on Human Health	55
The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors	53
Prospecting Human Milk Oligosaccharides as a Defense Against Viral Infections	53
Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19	52
Exogenous Nitric Oxide Improves Antibiotic Susceptibility in Resistant Bacteria	50

Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease	50
Emerging Vaccine-Breakthrough SARS-CoV-2 Variants	47
Reproducible Breath Metabolite Changes in Children with SARS-CoV-2 Infection	45
Current Perspective of Antiviral Strategies against COVID-19	45
Two Years into the COVID-19 Pandemic: Lessons Learned	45
The Antibacterial Research and Development Pipeline Needs Urgent Solutions	42
Codelivery of Sustainable Antimicrobial Agents and Platelet-Derived Growth Factor via Biodegradable Nanofibers for Repair of Diabetic Infectious Wounds	41
Combined Efficacy of an Antimicrobial Cationic Peptide Polymer with Conventional Antibiotics to Combat Multidrug-Resistant Pathogens	41
Plasmodium Kinases as Potential Drug Targets for Malaria: Challenges and Opportunities	39
Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19	39
Structure–Activity Relationship Studies of Acetazolamide-Based Carbonic Anhydrase Inhibitors with Activity against Neisseria gonorrhoeae	38
Mucin-Degrading Microbes Release Monosaccharides That Chemoattract Clostridioides difficile and Facilitate Colonization of the Human Intestinal Mucus Layer	38
Kanamycin Uptake into Escherichia coli Is Facilitated by OmpF and OmpC Porin Channels Located in the Outer Membrane	38